Home > Publications database > Ruthenium-based complex nanocarriers for cancer therapy |
Journal Article | PreJuSER-20252 |
; ; ; ; ; ; ; ;
2012
Elsevier Science
Amsterdam [u.a.]
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.biomaterials.2012.01.057
Abstract: A new organometallic ruthenium complex, named AziRu, along with three amphiphilic nucleoside-based ruthenium complexes, ToThyRu, HoThyRu and DoHuRu, incorporating AziRu in their skeleton, have been synthesized, stabilized in POPC phospholipid formulations and studied for their antineoplastic activity. Self-aggregation behavior of these complexes was investigated, showing that the three synthesized AziRu derivatives able to form liposomes and, under specific conditions, elongated micelles. The formulations prepared in POPC proved to be stable for months and showed high in vitro antiproliferative activity. The here described results open new scenarios in the design of innovative transition metal-based supramolecular systems for anticancer drugs vectorization.
Keyword(s): Animals (MeSH) ; Antineoplastic Agents: administration & dosage (MeSH) ; Antineoplastic Agents: chemistry (MeSH) ; Cell Line, Tumor (MeSH) ; Cell Survival: drug effects (MeSH) ; Drug Carriers (MeSH) ; Drug Stability (MeSH) ; Humans (MeSH) ; Liposomes (MeSH) ; Materials Testing (MeSH) ; Microscopy, Fluorescence (MeSH) ; Nanoparticles: administration & dosage (MeSH) ; Nanoparticles: chemistry (MeSH) ; Neoplasms: drug therapy (MeSH) ; Organometallic Compounds: administration & dosage (MeSH) ; Organometallic Compounds: chemistry (MeSH) ; Rats (MeSH) ; Ruthenium: administration & dosage (MeSH) ; Ruthenium: chemistry (MeSH) ; Health and Life (1st) ; Health and Life (1st) ; Biology (2nd) ; Antineoplastic Agents ; Drug Carriers ; Liposomes ; Organometallic Compounds ; Ruthenium ; J ; Ruthenium-based complexes (auto) ; Antineoplastic agents (auto) ; Nanoaggregates (auto) ; Anti-proliferative activity (auto)
![]() |
The record appears in these collections: |